<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03219125</url>
  </required_header>
  <id_info>
    <org_study_id>2016_44</org_study_id>
    <secondary_id>2017-A00472-51</secondary_id>
    <nct_id>NCT03219125</nct_id>
  </id_info>
  <brief_title>Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women</brief_title>
  <acronym>ADIMOS</acronym>
  <official_title>Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women: a Case-control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to determine in a case-control study if an association exist between bone
      marrow adiposity and fragility fractures in post-menopausal women.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2018</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bone marrow fat content at lumbar spine</measure>
    <time_frame>24 months</time_frame>
    <description>Total bone marrow fat content (percentage) at lumbar spine (L1-L4) measured with magnetic resonance imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone marrow fat content at total hip</measure>
    <time_frame>24 months</time_frame>
    <description>Total bone marrow fat content (percentage) at total hip measured with magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density at lumbar spine</measure>
    <time_frame>24 months</time_frame>
    <description>Bone mineral density (g/cm2) at lumbar spine (L1-L4) measured by DXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density at total hip</measure>
    <time_frame>24 months</time_frame>
    <description>Bone mineral density (g/cm2) at total hip measured by DXA</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">194</enrollment>
  <condition>Fractures, Bone</condition>
  <condition>Bone Marrow Disease</condition>
  <condition>Fat Disorder</condition>
  <condition>Adiposity</condition>
  <arm_group>
    <arm_group_label>Group 1 (cases)</arm_group_label>
    <description>occurence of incident major osteoporotic fracture less than 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 (controls)</arm_group_label>
    <description>no history of fragility fracture</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dixon Magnetic Resonance Imaging</intervention_name>
    <description>MRI of the lumbar spine (L1 to L4) and hip (non-dominant) for the measurement of Ad Med. (In%) by the DIXON sequence.</description>
    <arm_group_label>Group 1 (cases)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dual-energy X-ray absorptiometry (DXA)</intervention_name>
    <description>Subjects will undergo DXA scan to assess total body (less head) and lumbar spine bone mineral density.</description>
    <arm_group_label>Group 2 (controls)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Post-menopausal women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  post-menopausal women : 50-90 years old

          -  Group 1 (cases) : occurence of incident major osteoporotic fracture less than 12 weeks

          -  Group 2 (controls) : no history of fragility fracture

        Exclusion Criteria:

          -  Implants that are contraindicated for the magnetic resonance (MR) examination.

          -  Implants that might create a health risk or other problem during an MR exam include:
             1) cardiac pacemaker or implantable defibrillator, 2) catheter that has metal
             components that may pose a risk of a burn injury, 3) a ferromagnetic metal clip placed
             to prevent bleeding from an intracranial aneurysm, 4) an implanted medication pump
             (such as that used to deliver insulin or a pain-relieving drug), and 5) a cochlear
             implant.

          -  body mass index [BMI] &gt;38 kg/m2, weight &gt;140 kg

          -  Disease or current use of medications known to affect bone density, including oral
             glucocorticoids, treatments for osteoporosis (bisphosphonates, raloxifene, calcitonin,
             or PTH), hormone therapy.

          -  Chronic kidney disease with DFG &lt;30 ml/mn
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Paccou, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julien Paccou, MD, PhD</last_name>
    <phone>3 20 44 69 26</phone>
    <phone_ext>+33</phone_ext>
    <email>julien.paccou@chru-lille.fr</email>
  </overall_contact>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2017</study_first_submitted>
  <study_first_submitted_qc>July 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2017</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>marrow adipose tissue</keyword>
  <keyword>bone marrow adiposity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

